Logo image of HANS.CA

HANSTONE GOLD CORP (HANS.CA) Stock Fundamental Analysis

TSX-V:HANS - TSX Venture Exchange - CA4113511097 - Common Stock - Currency: CAD

0.025  0 (-16.67%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to HANS. HANS was compared to 0 industry peers in the Unkown industry. HANS has a bad profitability rating. Also its financial health evaluation is rather negative. HANS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

HANS had negative earnings in the past year.
In the past year HANS has reported a negative cash flow from operations.
HANS had negative earnings in each of the past 5 years.
In the past 5 years HANS reported 4 times negative operating cash flow.
HANS.CA Yearly Net Income VS EBIT VS OCF VS FCFHANS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -1M -2M -3M -4M

1.2 Ratios

Industry RankSector Rank
ROA -15.92%
ROE -59.81%
ROIC N/A
ROA(3y)-91.73%
ROA(5y)-85.08%
ROE(3y)-176.83%
ROE(5y)-138.06%
ROIC(3y)N/A
ROIC(5y)N/A
HANS.CA Yearly ROA, ROE, ROICHANS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -50 -100 -150 -200 -250

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HANS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HANS.CA Yearly Profit, Operating, Gross MarginsHANS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, HANS has more shares outstanding
Compared to 5 years ago, HANS has more shares outstanding
HANS has a worse debt/assets ratio than last year.
HANS.CA Yearly Shares OutstandingHANS.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
HANS.CA Yearly Total Debt VS Total AssetsHANS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M

2.2 Solvency

Based on the Altman-Z score of -6.08, we must say that HANS is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 1.06 is on the high side and indicates that HANS has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Altman-Z -6.08
ROIC/WACCN/A
WACCN/A
HANS.CA Yearly LT Debt VS Equity VS FCFHANS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 1M -1M -2M -3M

2.3 Liquidity

HANS has a Current Ratio of 0.04. This is a bad value and indicates that HANS is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.04 indicates that HANS may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
HANS.CA Yearly Current Assets VS Current LiabilitesHANS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M

More info and screens

0

3. Growth

3.1 Past

HANS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.66%, which is quite impressive.
EPS 1Y (TTM)69.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.73%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HANS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HANS.CA Price Earnings VS Forward Price EarningsHANS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HANS.CA Per share dataHANS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HANS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HANSTONE GOLD CORP

TSX-V:HANS (5/8/2025, 7:00:00 PM)

0.025

0 (-16.67%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-22 2023-08-22
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners40.48%
Ins Owner ChangeN/A
Market Cap1.29M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.12
P/tB 2.12
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.92%
ROE -59.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-91.73%
ROA(5y)-85.08%
ROE(3y)-176.83%
ROE(5y)-138.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 922.27%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -6.08
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)263.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.73%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.36%
OCF growth 3YN/A
OCF growth 5YN/A